Terms: = Thyroid cancer AND TET2, Q6N021, MGC125715, KIAA1546, FLJ20032, ENSG00000168769, 54790
10 results:
1. [Clinicopathological features of thyroid-like low-grade nasopharyngeal papillary adenocarcinoma].
Zhu M; Li J; Zheng WH; Wu MJ
Zhonghua Bing Li Xue Za Zhi; 2023 Aug; 52(8):820-826. PubMed ID: 37527987
[No Abstract] [Full Text] [Related]
2. INI1-Deficient thyroid Carcinoma is an Aggressive Disease with Epithelioid and Rhabdoid Phenotype. A Case Report, Survey of INI1 Expression in thyroid Lesions and Literature Review.
Liu Z; Seshadri M; Gupta V; Papanicolau-Sengos A; Merzianu M
Head Neck Pathol; 2021 Dec; 15(4):1246-1252. PubMed ID: 34057693
[TBL] [Abstract] [Full Text] [Related]
3. thyroid MALT lymphoma: self-harm to gain potential T-cell help.
Wu F; Watanabe N; Tzioni MM; Akarca A; Zhang C; Li Y; Chen Z; Cucco F; Carmell N; Noh JY; Ito K; Dobson R; Moody S; Yao W; Zhang W; Liu W; Liu H; Okosun J; Chott A; Bi Y; Chuang SS; Raderer M; Li JY; Marafioti T; Du MQ
Leukemia; 2021 Dec; 35(12):3497-3508. PubMed ID: 34021249
[TBL] [Abstract] [Full Text] [Related]
4. Bcl-2-negative IGH-BCL2 translocation-negative follicular lymphoma of the thyroid differs genetically and epigenetically from Bcl-2-positive IGH-BCL2 translocation-positive follicular lymphoma.
Hamamoto Y; Kukita Y; Kitamura M; Kurashige M; Masaie H; Fuji S; Ishikawa J; Honma K; Wakasa T; Hanamoto H; Hirokawa M; Suzuki A; Morii E; Nakatsuka SI
Histopathology; 2021 Oct; 79(4):521-532. PubMed ID: 33829512
[TBL] [Abstract] [Full Text] [Related]
5. Alterations of regulatory factors and DNA methylation pattern in thyroid cancer.
Iancu IV; Botezatu A; Plesa A; Huica I; Fudulu A; Albulescu A; Bostan M; Mihaila M; Grancea C; Manda DA; Dobrescu R; Vladoiu SV; Anton G; Badiu CV
Cancer Biomark; 2020; 28(2):255-268. PubMed ID: 32390600
[TBL] [Abstract] [Full Text] [Related]
6. Immunohistochemical analysis of IDH2 R172 hotspot mutations in breast papillary neoplasms: applications in the diagnosis of tall cell carcinoma with reverse polarity.
Pareja F; da Silva EM; Frosina D; Geyer FC; Lozada JR; Basili T; Da Cruz Paula A; Zhong E; Derakhshan F; D'Alfonso T; Wen HY; Giri DD; Hayes MM; Krings G; Bhargava R; Palazzo JP; Rakha EA; Hoda SA; Sanders ME; Collins LC; Schnitt SJ; Chen YY; Weigelt B; Jungbluth AA; Reis-Filho JS; Brogi E
Mod Pathol; 2020 Jun; 33(6):1056-1064. PubMed ID: 31896809
[TBL] [Abstract] [Full Text] [Related]
7. Immunity drives
Collignon E; Canale A; Al Wardi C; Bizet M; Calonne E; Dedeurwaerder S; Garaud S; Naveaux C; Barham W; Wilson A; Bouchat S; Hubert P; Van Lint C; Yull F; Sotiriou C; Willard-Gallo K; Noel A; Fuks F
Sci Adv; 2018 Jun; 4(6):eaap7309. PubMed ID: 29938218
[TBL] [Abstract] [Full Text] [Related]
8. Novel
Moody S; Thompson JS; Chuang SS; Liu H; Raderer M; Vassiliou G; Wlodarska I; Wu F; Cogliatti S; Robson A; Ashton-Key M; Bi Y; Goodlad J; Du MQ
Haematologica; 2018 Aug; 103(8):1329-1336. PubMed ID: 29674500
[TBL] [Abstract] [Full Text] [Related]
9. Solid papillary breast carcinomas resembling the tall cell variant of papillary thyroid neoplasms (solid papillary carcinomas with reverse polarity) harbour recurrent mutations affecting IDH2 and PIK3CA: a validation cohort.
Lozada JR; Basili T; Pareja F; Alemar B; Paula ADC; Gularte-Merida R; Giri DD; Querzoli P; Cserni G; Rakha EA; Foschini MP; Reis-Filho JS; Brogi E; Weigelt B; Geyer FC
Histopathology; 2018 Aug; 73(2):339-344. PubMed ID: 29603332
[TBL] [Abstract] [Full Text] [Related]
10. Identification of Novel Oncogenic Mutations in thyroid cancer.
Pitt SC; Hernandez RA; Nehs MA; Gawande AA; Moore FD; Ruan DT; Cho NL
J Am Coll Surg; 2016 Jun; 222(6):1036-1043.e2. PubMed ID: 27010584
[TBL] [Abstract] [Full Text] [Related]
